{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:32:20Z","timestamp":1793770340319,"version":"4.6.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"National Institute of Health and Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Government of Singapore Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.biomaterials.2026.124717","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:10:11Z","timestamp":1792451411000},"page":"124717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Hybrid nanovesicle artificial antigen-presenting cells integrate endogenous tumor antigen display with senescence-mimetic erythrocyte membrane-directed splenic T-cell priming"],"prefix":"10.1016","volume":"338","author":[{"given":"Zhijuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6072-763X","authenticated-orcid":false,"given":"Sha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huize","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muye","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8613-4285","authenticated-orcid":false,"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biomaterials.2026.124717_bib1","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41565-025-02008-w","article-title":"Nanotechnology for CAR T cells and tumour-infiltrating lymphocyte therapies","volume":"20","author":"Lafuente-Gomez","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124717_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf3700","article-title":"TCR-engineered T cell therapy in solid tumors: state of the art and perspectives","volume":"9","author":"Baulu","year":"2023","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124717_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41565-020-00822-y","article-title":"Nanomaterials for T-cell cancer immunotherapy","volume":"16","author":"Gong","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124717_bib4","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41587-024-02435-5","article-title":"TCR cell therapies vanquish solid tumors - finally","volume":"42","author":"Harrison","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124717_bib5","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa2210233","article-title":"Tumor-Infiltrating lymphocyte therapy or ipilimumab in advanced melanoma","volume":"387","author":"Rohaan","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124717_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41467-024-55420-6","article-title":"Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies","volume":"16","author":"Kuilman","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124717_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jcyt.2018.11.004","article-title":"Tumor-infiltrating lymphocytes: streamlining a complex manufacturing process","volume":"21","author":"Hopewell","year":"2019","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124717_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41571-024-00959-y","article-title":"Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks","volume":"22","author":"Diorio","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7971","key":"10.1016\/j.biomaterials.2026.124717_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","article-title":"CAR T therapy beyond cancer: the evolution of a living drug","volume":"619","author":"Baker","year":"2023","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124717_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41573-025-01291-5","article-title":"In vivo chimeric antigen receptor (CAR)-T cell therapy","volume":"25","author":"Bot","year":"2026","journal-title":"Nat. Rev. Drug Discov."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124717_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202310168","article-title":"In situ reprogramming of immune cells using synthetic nanomaterials","volume":"36","author":"Nie","year":"2024","journal-title":"Adv Mater"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124717_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41577-025-01174-1","article-title":"In vivo CAR engineering for immunotherapy","volume":"25","author":"Li","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124717_bib13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41578-025-00814-1","article-title":"Next-generation materials for nucleic acid delivery","volume":"10","author":"van der Meel","year":"2025","journal-title":"Nat. Rev. Mater."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124717_bib14","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41565-023-01333-2","article-title":"Membrane-anchored DNA nanojunctions enable closer antigen-presenting cell-T-cell contact in elevated T-cell receptor triggering","volume":"18","author":"Du","year":"2023","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124717_bib15","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-21-0502","article-title":"Reprogramming cancer into antigen-presenting cells as a novel immunotherapy","volume":"13","author":"Linde","year":"2023","journal-title":"Cancer Discov."},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124717_bib16","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1021\/jacs.1c09316","article-title":"DNA engineered lymphocyte-based homologous targeting artificial antigen-presenting cells for personalized cancer immunotherapy","volume":"144","author":"Sun","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124717_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00018-024-05412-y","article-title":"Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells","volume":"81","author":"Li","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124717_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt0202-143","article-title":"Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB","volume":"20","author":"Maus","year":"2002","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124717_bib19","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1021\/acsnano.2c06211","article-title":"Artificial antigen-presenting cell topology dictates T cell activation","volume":"16","author":"Wauters","year":"2022","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124717_bib20","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/s41565-024-01781-4","article-title":"Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies","volume":"19","author":"Zhu","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"48","key":"10.1016\/j.biomaterials.2026.124717_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add1106","article-title":"DNA origami-based artificial antigen-presenting cells for adoptive T cell therapy","volume":"8","author":"Sun","year":"2022","journal-title":"Sci. Adv."},{"issue":"35","key":"10.1016\/j.biomaterials.2026.124717_bib22","doi-asserted-by":"crossref","first-page":"14842","DOI":"10.1002\/anie.202003367","article-title":"DNA-Edited ligand positioning on red blood cells to enable optimized T cell activation for adoptive immunotherapy","volume":"59","author":"Sun","year":"2020","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124717_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s44222-025-00316-3","article-title":"Interfacial T cell engineering","volume":"3","author":"Alapan","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"issue":"41","key":"10.1016\/j.biomaterials.2026.124717_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202426047","article-title":"Strategies to design and optimize artificial antigen\u2010presenting cells for T cell expansion in cancer immunotherapy","volume":"35","author":"Nguyen","year":"2025","journal-title":"Adv. Funct. Mater."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124717_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41568-024-00787-3","article-title":"Dendritic cell maturation in cancer","volume":"25","author":"Moon","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124717_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"8079","key":"10.1016\/j.biomaterials.2026.124717_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-025-09202-9","article-title":"Rescuing dendritic cell interstitial motility sustains antitumour immunity","volume":"645","author":"Tang","year":"2025","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124717_bib28","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41587-024-02505-8","article-title":"Targeting peptide antigens using a multiallelic MHC I-binding system","volume":"43","author":"Du","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"50","key":"10.1016\/j.biomaterials.2026.124717_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd1631","article-title":"Size-transformable antigen-presenting cell-mimicking nanovesicles potentiate effective cancer immunotherapy","volume":"6","author":"Yang","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124717_bib30","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1038\/s41467-022-33597-y","article-title":"Nanoparticle-based modulation of CD4(+) T cell effector and helper functions enhances adoptive immunotherapy","volume":"13","author":"Isser","year":"2022","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124717_bib31","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/s41551-024-01272-w","article-title":"Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapies","volume":"8","author":"Liu","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124717_bib32","article-title":"Cryo\u2010Shocked tumor\u2010reprogrammed sonosensitive antigen\u2010presenting cells improving","volume":"37","author":"Xindi Qian","year":"2025","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124717_bib33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124717_bib34","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","article-title":"Exploiting senescence for the treatment of cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124717_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12943-024-01973-5","article-title":"The senescence journey in cancer immunoediting","volume":"23","author":"Zingoni","year":"2024","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124717_bib36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2159-8290.CD-22-0523","article-title":"Cellular senescence is immunogenic and promotes antitumor immunity","volume":"13","author":"Marin","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biomaterials.2026.124717_bib37","article-title":"Leveraging senescent cancer cell membrane to potentiate cancer immunotherapy through biomimetic nanovaccine","author":"Yang","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"32","key":"10.1016\/j.biomaterials.2026.124717_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adma.73231","article-title":"Non-Engineered physiologically modulated nanovesicles Augment Antitumor immune responses via dual-pathway T cell activation","volume":"38","author":"Fan","year":"2026","journal-title":"Adv Mater"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124717_bib39","article-title":"Red blood cell\u2013derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy","author":"Xiao Han","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2026.124717_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00926740","article-title":"Alessandra Fraternale, Mauro Magnani Modulated red blood cell survival by membrane protein clustering","volume":"144","author":"Laura Chiarantini","year":"1995","journal-title":"Mol. Cell. Biochem."},{"issue":"7980","key":"10.1016\/j.biomaterials.2026.124717_bib41","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41586-023-06498-3","article-title":"Spatial predictors of immunotherapy response in triple-negative breast cancer","volume":"621","author":"Wang","year":"2023","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124717_bib42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nnano.2017.57","article-title":"In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers","volume":"12","author":"Smith","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"6753","key":"10.1016\/j.biomaterials.2026.124717_bib43","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1126\/science.ads8473","article-title":"In vivo CAR T cell generation to treat cancer and autoimmune disease","volume":"388","author":"Hunter","year":"2025","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124717_bib44","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41565-025-01954-9","article-title":"A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles","volume":"20","author":"Chen","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124717_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","article-title":"Cross-priming in cancer immunology and immunotherapy","volume":"25","author":"Luri-Rey","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124717_bib46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s44222-023-00030-y","article-title":"Engineering cytokine therapeutics","volume":"1","author":"Deckers","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124717_bib47","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s41565-024-01615-3","article-title":"Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination","volume":"19","author":"Zeng","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124717_bib48","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41565-020-0719-0","article-title":"Role of nanoscale antigen organization on B-cell activation probed using DNA origami","volume":"15","author":"Veneziano","year":"2020","journal-title":"Nat. Nanotechnol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226007416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226007416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:21:16Z","timestamp":1793769676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226007416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":48,"alternative-id":["S0142961226007416"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124717","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hybrid nanovesicle artificial antigen-presenting cells integrate endogenous tumor antigen display with senescence-mimetic erythrocyte membrane-directed splenic T-cell priming","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124717"}}